• Introduction to Thyroid Cancer
    • Introduction to Thyroid Cancer

      Thyroid cancer is the most common endocrine system malignant tumor, accounting for about 1% of the total incidence of systemic malignant tumors. It can occur at any age but is more common in young adults.
      The diagnosis of most thyroid cancer begin with thyroid nodules and hence it is critical to determine whether the nodules are benign and malignant . Thyroid cancer can be classified into four pathological types of papillary carcinoma, follicular carcinoma, undifferentiated carcinoma and medullary carcinoma. Papillary carcinoma with lower malignant degree and better prognosis is the most common type.
      The prognosis and treatment of thyroid cancer of different pathological types are obviously different. The main treatment methods are surgical treatment, in addition to 131I treatment, radiotherapy, chemotherapy, targeted therapy and so on.

      Product Overview:
      Product Features:
      Suitable Patient Profile:
  • Significance of Gene Testing in Thyroid Cancer
    • Significance of Gene Testing in Thyroid Cancer

      1. Assist in the diagnosis of thyroid nodules as benign or malignant.
      2. Assist in prognostic evaluation and drug guidance for patients with thyroid cancer.
      3. Indicate the genetic risk of patients with thyroid medullary carcinoma and high-risk population.

      Product Overview:

      Product Features:

      Suitable Patient Profile:

  • Genetron in Thyroid Cancer Testing
    • Genetron in Thyroid Cancer Testing

      Professionally designed to cover thyroid cancer-associated genetic variants while simultaneously detecting DNA and RNA

      High specificity and sensitivity-more accurate and reliable test results

      Genetron’s One-step solution patented technology: fewer specimens, faster on-board and accurate sequencing

      Strong bioinformatics team, medical team and technology platform

      One test, multiple benefits: comprehensive product features, suggesting multiple information on genetics, treatment and prognosis

      Comprehensive product coverage, professional focus, more options (2 genes of thyroid molecular typing, full cycle 41 genes, solid tumor 825 genes)

      Product Overview:
      Product Features:
      Suitable Patient Profile:
  • Thyroid tumor full circle testing
    • Product Overview:

      Product Overview:

      Based on the NGS platform, Genetron's “one-step” patented technology provides genetic testing services for three types of thyroid fine needle aspiration (FNA), fresh surgical tissue and paraffin section (FFPE) of 41 genes related to thyroid cancer for genetic variation analysis

      Product Features:

      1. Comprehensive coverage of thyroid cancer diagnosis stage, treatment stage and follow-up stage
      2. Simultaneous testing of DNA and RNA and accurate identification of multiple fusion genes
      3. Four application scenarios of nodular and benign judgment, tumor recurrence risk and prognosis evaluation, clinical treatment tips and drug treatment guidance
      4. A complete FNA specimen can be sequenced, and a gene analysis report can be issued in 7 days to guide clinical treatment
      5. The product has been proven in hundreds of clinical samples with high specificity and sensitivity to ensure professional and reliable testing services

      Suitable Patient Profile:

      1. Newly diagnosed patients: to determine if thyroid nodule is benign and malignant
      2. Postoperative patients: recurrence risk screening and guidance, drug matching, and genetic screening
      3. Recurrent, refractory, poorly differentiated, undifferentiated patients: drug matching and treatment guidance
      4. Patients with medullary carcinoma: genetic screening, drug matchingand prognostic risk assessment

  • Onco PanScan™(tissue/blood)
    • Onco PanScan™(tissue/blood)

      Product Overview:

      Combined with Genetron’s universal tumor database, the solid tumor 825 genes testing covers an updated version of the WHO, NCCN, ESMO and other authoritative guidelines and expert consensus recommended test genes. Based on the high-throughput, highly sensitive NGS platform and 'hybrid capture' technology, solid tumor 825 genes testing can provide multi-dimensional immunotherapy related biomarker detection (TMB, MSI, PD-L1, immune efficacy related gene variation), so as to guide the individualized diagnosis and treatment of tumor patients more accurately, It also provides more comprehensive reference information for researchers.

      Product Features:

      1. Focus on 238 tumor drugs, covering 12 classic tumor signaling pathways, 45 chemotherapy drug related sites, 90 immunotherapy related genes, 149 tumor genetic susceptibility genes

      2. Comprehensive and real-time dynamic monitoring of recurrent metastasis and the mechanism of molecular change in drug-resistant patients, to achieve the full course of cancer monitoring and management

      3. Multi-dimensional immunotherapy assessmentTumor patients seeking more opportunities for targeted drugs or immunotherapy

      Suitable Patient Profile:

      Tumor patients seeking more opportunities for targeted drugs or immunotherapy

  • Assessment Process
    • Assessment Process
      Product Overview:
      Product Features:
      Suitable Patient Profile:
COPYRIGHT © 2020-2023泛生子. ALL RIGHTS RESERVED
Genetron Health Genetron Health Management
COPYRIGHT © 2020-2023泛生子. ALL RIGHTS RESERVED
Messages
  • *To
  • *Subject
  • *Name
  • *Tel
  • Work Unit
  • *Email
  • 详细说明:
  • Check code:
Genetron Health Genetron Health Management